Lia Halasz, M.D.

 

Lia Moriguchi Halasz MD
Assistant Professor

Contact Information
Address:  1959 NE Pacific St, Box 356043
Phone:  206-598-4100
Fax:  206-598-3786

Education

Institution

Years Attended

Degree(s)

Harvard College 1996-2000 A.B. Biochemical Sciences
Harvard Medical School 2001-2006 M.D.

Professional Experience

Company/Institution

Title

Years of Employment/Service

Brigham and Women’s Hospital, Boston, MA Internship in Internal Medicine 2006-2007
Harvard Radiation Oncology Program, Boston, MA Resident in Radiation Oncology 2007-2011

Certifications/Licensure:

Full License, State of Washington
Full License, State of Massachusetts

Honors:

2000    Public Service Fellowship, Carl and Lily Pforzheimer Foundation
2005    Research Training Fellowship, Howard Hughes Medical Institute
 

Focus of Clinical Practice:

Brain and spinal tumors, Radiation Oncology

 

Professional affiliations, committees, and leadership activities:

2007-present    Member, American Society for Radiation Oncology
2007-present    Member, American Society for Clinical Oncology
2011-present    Radiation Safety Committee, University of Washington, Seattle, WA

 

Research Interests/Activities:

Brain and spinal tumors

 

Current/Ongoing Research Projects/Clinical Trials:

Use of radiation therapy for central nervous system metastases using large databases.

Publications:

Manuscripts in Refereed Journals:

1. Yao MC, Yao CH, Halasz LM, Fuller P, Rexer CH, Wang SH, Jain R, Coyne RS, Chalker DL.  Identification of novel chromatin-associated proteins involved in programmed genome rearrangements in Tetrahymena.  J Cell Sci. 2007 Jun 15; 120 (Pt 12): 1978-1989. PMID: 17519286.

2. Halasz LM, Bussiere MR, Dennis ER, Niemierko A, Chapman PH, Loeffler JS, Shih HA. Proton stereotactic radiosurgery for the treatment of benign meningiomas.  Int J Radiat Oncol Biol Phys. 2010 Oct 7. [Epub ahead of print]. PMID: 20934263.

3. Mak RH, Halasz LM, Schultz DJ, Tanaka C, Ancukiewicz M, Russell AH, Viswanathan AN.  Outcomes After Radiation Therapy with Concurrent Weekly Platinum-Based or 5-Fluorouracil-Based Chemotherapy for Squamous Cell Carcinoma of the Vulva. Gynecol Oncol. 2011 Jan;120(1):101-107. PMID: 20950845.

4. Varnum-Finney B*, Halasz LM*, Sun M, Radtke F, Gridley T, Bernstein ID. Notch2 promotes self renewal of hematopoietic stem and progenitor cells during marrow regeneration. J Clin Invest. 2011 Mar 1;121(3):1207-1216. PMID: 21285514. (*co-first authors)

5. Halasz LM, Sreedhara M, Chen Y, Bellon JR, Punglia RS, Wong JS, Harris JR, Brock JE. Improved outcomes of breast-conserving therapy for ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. In press.

Other Publications:

1. Halasz LM, Choi NC. Does prophylactic cranial irradiation reduce the incidence of brain metastases in extensive small-cell lung cancer?  Nat Clin Pract Oncol. 2008 Jun; 5(6): 308-309. PMID: 18431375.

2. Brock JE, Halasz LM. A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial: Pinder SE, Duggan C, Ellis IO, et al.  Br J Cancer. 103: 94-100. Breast Diseases: A Year Book Quarterly. 2011; 22(1): 47-49.

 


  • SEATTLE, WASHINGTON